FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2394-2396 December 1, 2005 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Muthukumar, T. PubMed Citation

In comparing current clinical outcomes in renal transplantation with those of 30 years ago,¹ graft failure from immunologic factors and death from opportunistic infection in the first year after transplantation are no longer common clinical outcomes. The therapeutic regimens used today to prevent and treat rejection or infection among renal-transplant recipients bear only a small resemblance to those used 30 years ago.

In contrast, the diagnostic strategies used to detect rejection and distinguish it from other causes of renal dysfunction have not budged during the past two decades. A rise in the level of serum creatinine suggests allograft dysfunction, but . . . [Full Text of this Article]

Source Information

From the Harvard Medical School, Beth Israel Deaconess Medical Center, Boston.

This article has been cited by other articles:

• Baxter-Lowe, L. A., Busch, M. P. (2006). Tracking microchimeric DNA in plasma to diagnose and manage organ transplant rejection.. Clin. Chem. 52: 559-561 [Full Text]